Zhuang Mingzhe sold $221K of IBEX

Zhuang Mingzhe sold 5,522 shares of IBEX Ltd (IBEX) at $40.10 ($0.22M total) on 2026-09-15.

Original reporting
SEC EDGAR · Zhuang Mingzhe
Published Sep 16, 2026, 9:10 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 16, 2026, 9:30 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
MARKET
Neutral
AI market analysis
Mentioned
$IBEX
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

Low
01

Why it matters

The insider sale represents a modest reduction in holdings and may signal limited confidence, but the amount is small relative to the company's market cap.

02

Market read

Minor insider transaction with limited immediate market impact.

03

What to watch

none

Relevance 4/10Novelty 4/10Timing: filed today

Background

SEC Form 4 filing reporting a director's sale of 5,522 shares of IBEX Ltd at $40.10 per share.

Market effects

none

none

none

Counterpoint

none

Key entities

  • IBEX Ltd

    Issuer of the shares sold.

  • Zhuang Mingzhe

    Director of IBEX Ltd who sold shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$IBEXHighAI 8/10

IBEX (IBEX) Turns The AI Threat Into Its Biggest Growth Engine

IBEX (IBEX) reported record full-year revenue of $644.1M, up 15.4%, and Q4 revenue of $164.3M, up 11.6%. Growth was driven by HealthTech, Technology, and Travel & Logistics. AI partnerships with Philippine Airlines and BJ's Wholesale showed strong results. Q4 net income fell to $8.7M, and EPS dropped to $0.59 due to training and operational costs.

$IBEXMedAI 8/10

IBEX (IBEX) Q4 2026 Earnings Call Transcript

IBEX (IBEX) reported fiscal year 2026 revenue of $644.1 million, up 15.4%, with Q4 revenue at $164.3 million, up 11.6%. Adjusted EBITDA reached $82.4 million, a 14.5% increase. HealthTech revenue grew 38.5% to $114 million. Guidance for 2027 projects revenue of $700M-$715M and adjusted EBITDA of $90M-$94M. The company highlighted growth in AI-powered services and strategic partnerships.

$IBEXHigh

IBEX Reports Record Fiscal Year 2026 Financial Results, Introduces Fiscal Year 2027 Guidance

IBEX Ltd (IBEX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 IBEX Reports Record Fiscal Year 2026 Financial Results, Introduces Fiscal Year 2027 Guidance • Record fourth quarter revenue grew 12% versus prior year quarter, sixth consecutive quarter of double-digit growth • Nine new logo wins in the fourth quarter, including two